ArticleScientific reports2025
Sinusoidal exponential distribution for modeling elevated creatinine kinase level as the initial presentation of Covid-19.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper is devoted to deriving a new lifetime distribution based on a sine function to model different initial symptoms of Covid-19 patients that initially present as muscle weakness with increased Creatinine Kinase (CK), without fever or respiratory symptoms. The new distribution is called Sinusoidal Exponential Distribution. Among its interesting properties, it has the feature of possessing a periodic hazard rate function. Some of its mathematical properties are studied, including moments, moment generating function, hazard rate function, mean residual life function, reversed failure rate and Lorenz and Bonferroni Curves. The estimation of its parameter is investigated using the maximum likelihood estimation. A simulation study is carried out to assess the performance of the obtained estimators for small and large samples. Areal-life data set is considered to illustrate the usefulness and the flexibility of the proposed distribution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.